Filing Flows › Macrogenics (MGNX) › Next earnings date
Macrogenics (MGNX) earnings on Nov 12, 2026: what to expect
Macrogenics (MGNX) is expected to report earnings on Nov 12, 2026 (estimated), in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.13 (−$0.17 to −$0.08, 2 estimates) on revenue of $39.2M, against $0.27 and $72.8M a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 71% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS $0.28 on revenue of $187M, against the analysts' −$0.13.
The last report
Macrogenics reported revenue of $32.8M for the second quarter 2026 (+378% Y/Y), net earnings $19.5M: Collaborative and other agreements $25.5M, Royalty revenue $7.3M. How it makes money → · Every quarter →
Macrogenics' latest quarter
Macrogenics, Q2 2026: revenue $32.8M (+378% year over year), operating margin -42.2%, net earnings $19.5M, operating cash flow −$40.7M. The chart follows the revenue to costs, profit and cash.
Questions
When does MGNX report earnings?
Macrogenics is expected to report on Nov 12, 2026 (estimated).
What are analysts expecting from Macrogenics?
EPS of −$0.13 and revenue of $39.2M for the quarter.
Does Macrogenics usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.